Tilray Brands, Inc. to Announce Third Quarter 2024 Financial Results on April 9, 2024
NEW YORK and LEAMINGTON, Ontario, March 28, 2024 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company, today announced that the Company will release financial results for its third quarter ended February 29, 2024, on April 9, 2024.
Live Audio Webcast
Tilray will host a live audio webcast to discuss these results at 8:30 am Eastern Time, which can be accessed on the Investors section of Tilray's website at www.Tilray.com. A replay will be available and archived on the Company’s website.
Retail Investor Q&A
Tilray Brands stockholders can submit and upvote questions via the stockholder Q&A platform Say Technologies beginning today and until April 8, 2024. To submit questions ahead of the webcast, please visit the Say Technologies platform at https://app.saytechnologies.com/tilray-brands-2024-q3.
About Tilray Brands
Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY) is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is changing people’s lives for the better – one person at a time – by inspiring and empowering the worldwide community to live their very best life by providing them with products that meet the needs of their mind, body, and soul and invoke a sense of wellbeing. Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray’s unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
For more information on how we open a world of well-being, visit, www.Tilray.com and follow @tilray on all social platforms.
Contacts:
Media:
Berrin Noorata
news@tilray.com
Investors
Raphael Gross
203-682-8253
Raphael.Gross@icrinc.com
Upcoming Life Sciences Events
- November 2024
- Philadelphia: Advanced Therapies USA
- London: Inv€$tival Showcase
- EABR Nanoparticles Platform for Hybrid mRNA Vaccine
Latest company news
MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results